These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25360644)

  • 1. [Effects of eukaryotic translation initiation factor 5A2 down-regulation by small interfering RNA on aggressiveness of MKN28 human].
    Meng QB; Yu JC; Kang WM; Ma ZQ; Zhou L; Ye X; Cao ZJ; Tian SB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Oct; 36(5):482-7. PubMed ID: 25360644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of eukaryotic translation initiation factor 5A2 (EIF5A2) correlates with cell aggressiveness and poor survival in gastric cancer.
    Meng QB; Kang WM; Yu JC; Liu YQ; Ma ZQ; Zhou L; Cui QC; Zhou WX
    PLoS One; 2015; 10(3):e0119229. PubMed ID: 25793713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer.
    Tian SB; Yu JC; Liu YQ; Kang WM; Ma ZQ; Ye X; Yan C
    World J Gastroenterol; 2015 Aug; 21(31):9337-47. PubMed ID: 26309359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sonic Hedgehog-GLI Family Zinc Finger 1 Signaling Pathway Promotes the Growth and Migration of Pancreatic Cancer Cells by Regulating the Transcription of Eukaryotic Translation Initiation Factor 5A2.
    Xu X; Liu H; Zhang H; Dai W; Guo C; Xie C; Wei S; He S; Xu X
    Pancreas; 2015 Nov; 44(8):1252-8. PubMed ID: 26465952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-588 regulates migration capacity and invasiveness of renal cancer cells by targeting EIF5A2.
    Dong JS; Wu B; Zha ZL
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10248-10256. PubMed ID: 31841179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition.
    Zhu W; Cai MY; Tong ZT; Dong SS; Mai SJ; Liao YJ; Bian XW; Lin MC; Kung HF; Zeng YX; Guan XY; Xie D
    Gut; 2012 Apr; 61(4):562-75. PubMed ID: 21813470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eukaryotic translation initiation factor 5A2 regulates the migration and invasion of hepatocellular carcinoma cells via pathways involving reactive oxygen species.
    Liu RR; Lv YS; Tang YX; Wang YF; Chen XL; Zheng XX; Xie SZ; Cai Y; Yu J; Zhang XN
    Oncotarget; 2016 Apr; 7(17):24348-60. PubMed ID: 27028999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EIF5A2 Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Growth by Modulating TGF- Signals.
    Hao F; Zhu Q; Lu L; Sun S; Huang Y; Zhang J; Liu Z; Miao Y; Jiao X; Chen D
    Oncol Res; 2020 Sep; 28(4):345-355. PubMed ID: 32138807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of MTA1 on biological behaviors of gastric cancer cells].
    Wang JS; Qian HL; Wang HJ; Xu DK
    Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):580-586. PubMed ID: 30139027
    [No Abstract]   [Full Text] [Related]  

  • 10. Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis.
    Bai HY; Liao YJ; Cai MY; Ma NF; Zhang Q; Chen JW; Zhang JX; Wang FW; Wang CY; Chen WH; Jin XH; Xu RH; Guan XY; Xie D
    Stem Cells; 2018 Feb; 36(2):180-191. PubMed ID: 29119708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermo-chemotherapy inhibits the proliferation and metastasis of gastric cancer cells via suppression of EIF5A2 expression.
    Ba MC; Ba Z; Cui SZ; Gong YF; Chen C; Lin KP; Wu YB; Tu YN
    Onco Targets Ther; 2019; 12():6275-6284. PubMed ID: 31496731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma.
    Tang DJ; Dong SS; Ma NF; Xie D; Chen L; Fu L; Lau SH; Li Y; Li Y; Guan XY
    Hepatology; 2010 Apr; 51(4):1255-63. PubMed ID: 20112425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-5189-3p Suppresses cell Proliferation, Invasion and Migration Through Targeting EIF5A2 in Laryngeal Squamous Cell Carcinoma.
    Lou D; Jia Q; Zhang H; Wang J; Liu L; Liu Z; Jia X; Wang J; Shan C
    Biochem Genet; 2024 Jun; 62(3):1603-1616. PubMed ID: 37656330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1.
    Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
    Cell Physiol Biochem; 2018; 46(1):93-106. PubMed ID: 29587281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro.
    Jiang Q; Zhang H; Zhang P
    J Exp Clin Cancer Res; 2011 May; 30(1):60. PubMed ID: 21595884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of eukaryotic translation initiation factor 5A2 enhances the therapeutic efficiency of doxorubicin in hepatocellular carcinoma cells by triggering lethal autophagy.
    Tang Y; Chen K; Luan X; Zhang J; Liu R; Zheng X; Xie S; Ke H; Zhang X; Chen W
    Int J Oncol; 2020 Dec; 57(6):1368-1380. PubMed ID: 33174013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
    Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
    Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between MTA1 expression and invasive and metastatic ability of cervical cancer cell].
    Han XY; Qian HL; Yang JJ; Zhang XY; Fu M; Liang X; Lin C; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):678-83. PubMed ID: 22176993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy.
    Huang PY; Zeng TT; Ban X; Li MQ; Zhang BZ; Zhu YH; Hua WF; Mai HQ; Zhang L; Guan XY; Li Y
    BMC Cancer; 2016 Aug; 16(1):669. PubMed ID: 27549330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting eIF5A2 inhibits prostate carcinogenesis, migration, invasion and metastasis
    Zhong X; Xiu H; Bi Y; Zhang H; Chang L; Diao H
    Bioengineered; 2020 Jan; 11(1):619-627. PubMed ID: 32522053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.